Seongun "Matt" Hong

Matt’s intellectual property-focused practice includes patent preparation and prosecution across a wide breadth of technologies, including artificial intelligence, distributed ledger technology, data security and cryptography, analytical chemistry, protective coatings, and medical devices. Matt is also experienced in conducting investigations and drafting opinions for freedom-to-operate, non-infringement, and validity analyses.

Before practicing law, Matt worked as a research specialist in a laboratory at the Emory University School of Medicine that focused on exploring molecular pathways through kidney protein expression. Matt’s educational background and research experience make him well-versed in the chemical and biological sciences.

Matt graduated, with honors, from the Emory University School of Law, where he served as an online editor on the Emory Law Journal. He also completed Georgia Tech’s TI:GER (Technological Innovation: Generating Economic Results) program, where he conducted intellectual property and commercialization research for medical device and wireless technology startups.

Publications

• Co-Authored Angiotensin II acts through the angiotensin 1a receptor to upregulate pendrin, 301 Am. J. Physiology - Renal Physiology F1314, September 2011
• Co-Authored Pendrin modulates ENaC function by changing luminal HCO3-, 21 J. Am. Soc. Nephrology 1928, November 2010